FDA Clearance Tracker · P950027-S004
HYALGAN
Last checked: Nov 20, 2026Latest source record: Aug 30, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Aug 30, 2000
Approved
Time to decision
616 days
Received Dec 23, 1998. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P950027-S004
- Device name
- HYALGAN
- Applicant
- Fidia Farmaceutici S.P.A.
- Applicant location
- Abano Terme
- Received
- Dec 23, 1998
- Decided
- Aug 30, 2000
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P950027
Device type
- Device type
- Acid, hyaluronic, intraarticular (MOZ)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL TO MODIFY LABELING, ADDING INFORMATION ABOUT THE CURRENT CLINICAL EXPERIENCE OF THE DEVICE.
Source documents
Other decisions for Fidia Farmaceutici S.P.A.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K191052 · Decided Jan 9, 2020 · 265 days after receipt
Device type: Lubricant, Personal (NUC) · Obstetrics & Gynecology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.